Latent tuberculosis before biologic therapy — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Treat latent tuberculosis before starting anti-TNF therapy
Positive IGRA in a high-risk patient before anti-TNF therapy indicates latent TB treatment to reduce reactivation risk. A normal CXR excludes obvious active pulmonary disease but does not exclude latent infection. BCG is not used therapeutically here, and starting anti-TNF without prophylaxis risks disseminated TB.
Reference: NICE NG33; BNF